ASP |
Asparaginase |
PEG |
Pegaspargase |
CAR |
Clinically-apparent reaction |
SI |
Silent inactivation |
CLIA |
Clinical Laboratory Improvement Amendments |
COG |
Children’s Oncology Group |
CTCAE |
Common Terminology Criteria for Adverse Events |
SOP |
Standards of Practice |
NCCN |
National Comprehensive Cancer Network |